BioAtla, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 123.46 million compared to USD 106.48 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.565 USD | +2.29% |
|
+10.95% | -36.18% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.18% | 73.62M | |
+31.87% | 52.73B | |
+37.35% | 39B | |
-9.45% | 38.52B | |
+27.44% | 30.38B | |
-12.26% | 26.39B | |
+10.73% | 26.08B | |
+44.44% | 14.15B | |
+32.12% | 12.6B | |
-5.38% | 11.51B |
- Stock Market
- Equities
- BCAB Stock
- News BioAtla, Inc.
- BioAtla, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023